197 related articles for article (PubMed ID: 2158445)
1. Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation.
Willems L; Heremans H; Chen G; Portetelle D; Billiau A; Burny A; Kettmann R
EMBO J; 1990 May; 9(5):1577-81. PubMed ID: 2158445
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of functional bovine leukemia virus (BLV) p34tax protein by recombinant baculoviruses.
Chen G; Willems L; Portetelle D; Willard-Gallo KE; Burny A; Gheysen D; Kettmann R
Virology; 1989 Nov; 173(1):343-7. PubMed ID: 2554576
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of bovine leukemia virus Tax protein is required for in vitro transformation but not for transactivation.
Willems L; Grimonpont C; Kerkhofs P; Capiau C; Gheysen D; Conrath K; Roussef R; Mamoun R; Portetelle D; Burny A; Adam E; Lefèbvre L; Twizere JC; Heremans H; Kettmann R
Oncogene; 1998 Apr; 16(17):2165-76. PubMed ID: 9619825
[TBL] [Abstract][Full Text] [Related]
4. Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer.
Burny A; Cleuter Y; Kettmann R; Mammerickx M; Marbaix G; Portetelle D; van den Broeke A; Willems L; Thomas R
Vet Microbiol; 1988 Jul; 17(3):197-218. PubMed ID: 2847391
[TBL] [Abstract][Full Text] [Related]
5. Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer.
Burny A; Cleuter Y; Kettmann R; Mammerickx M; Marbaix G; Portetelle D; Van den Broeke A; Willems L; Thomas R
Cancer Surv; 1987; 6(1):139-59. PubMed ID: 2891439
[TBL] [Abstract][Full Text] [Related]
6. Bovine leukemia: facts and hypotheses derived from the study of an infectious cancer.
Burny A; Cleuter Y; Kettmann R; Mammerickx M; Marbaix G; Portetelle D; Van den Broeke A; Willems L; Thomas R
Adv Vet Sci Comp Med; 1988; 32():149-70. PubMed ID: 2847501
[TBL] [Abstract][Full Text] [Related]
7. The bovine leukemia virus p34 is a transactivator protein.
Willems L; Gegonne A; Chen G; Burny A; Kettmann R; Ghysdael J
EMBO J; 1987 Nov; 6(11):3385-9. PubMed ID: 2828028
[TBL] [Abstract][Full Text] [Related]
8. The 3' region of bovine leukemia virus genome encodes a trans-activator protein.
Rosen CA; Sodroski JG; Willems L; Kettmann R; Campbell K; Zaya R; Burny A; Haseltine WA
EMBO J; 1986 Oct; 5(10):2585-9. PubMed ID: 3023049
[TBL] [Abstract][Full Text] [Related]
9. Expression of the bovine leukemia virus transactivator protein p34 by a recombinant vaccinia virus.
Willems L; Letellier C; Gonze M; Martin R; Kettmann R; Burny A; Meulemans G
Vet Immunol Immunopathol; 1989 Oct; 22(3):201-11. PubMed ID: 2560852
[TBL] [Abstract][Full Text] [Related]
10. Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells.
Rosen CA; Sodroski JG; Kettman R; Burny A; Haseltine WA
Science; 1985 Jan; 227(4684):320-2. PubMed ID: 2981432
[TBL] [Abstract][Full Text] [Related]
11. Recombinants from a proviral bovine leukemia virus genome corresponding to the 3' region transactivate viral LTR in NIH3T3 and non-infected FLK cells.
Noetzel U; Bauer D; Fischer U; Rosenthal S
Arch Exp Veterinarmed; 1990; 44(6):901-7. PubMed ID: 1966362
[TBL] [Abstract][Full Text] [Related]
12. Transfection of BLV containing DNA into NIH 3T3 cells.
Altaner C; Bán J; Zajac V; Kettmann R; Burny A
Neoplasma; 1985; 32(6):663-71. PubMed ID: 3003601
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts.
Schuster R; Gerlich WH; Schaefer S
Oncogene; 2000 Feb; 19(9):1173-80. PubMed ID: 10713705
[TBL] [Abstract][Full Text] [Related]
14. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
Derse D; Casey JW
Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat.
Dekoninck A; Calomme C; Nizet S; de Launoit Y; Burny A; Ghysdael J; Van Lint C
Oncogene; 2003 May; 22(19):2882-96. PubMed ID: 12771939
[TBL] [Abstract][Full Text] [Related]
16. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat.
Katoh I; Yoshinaka Y; Sagata N; Ikawa Y
Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987
[TBL] [Abstract][Full Text] [Related]
17. A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of the bovine leukemia virus long terminal repeat.
Willems L; Kettmann R; Chen G; Portetelle D; Burny A; Derse D
J Virol; 1992 Feb; 66(2):766-72. PubMed ID: 1309910
[TBL] [Abstract][Full Text] [Related]
18. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.
Kim YC; Song KS; Yoon G; Nam MJ; Ryu WS
Oncogene; 2001 Jan; 20(1):16-23. PubMed ID: 11244501
[TBL] [Abstract][Full Text] [Related]
19. Use of the bovine leukaemia virus LTR U3 promoter for expressing antisense antiviral RNAs and competitive inhibition of viral infection in cell culture.
Shayakhmetov D; Kovalenko D; Yurov G; Borisenko A; Tikchonenko T
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1941-8. PubMed ID: 9266992
[TBL] [Abstract][Full Text] [Related]
20. The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers.
Tajima S; Aida Y
J Virol; 2000 Dec; 74(23):10939-49. PubMed ID: 11069988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
